Member Info for scardey_cat

Interesting paragraph that may be applicable to Avacta. This kind of answers one thing I have been wondering about, that is, if Avacta's saliva test reached a certain stage at Porton Down, then would we have to start the process all over again, if we changed the sampling method. This implies that we don't necessarily have to start the process again.

2.11 DHSC will permit you to offer a Test which has been validated as passing Phase 3A, Phase 3B or the entirety of Phase 3 but it is not Validated for the same sampling method as the sampling method stated in your LFT Proposal (for example, it was validated for the nasopharyngeal sampling method and your LFT Proposal is for the same Test but using an oral pharyngeal sampling method). However, in such cases your LFT Proposal will only be evaluated if you can evidence that you have asked Porton Down to commence the process to confirm that its Validation remains valid for the alternative sampling method proposed in your LFT Proposal. For the avoidance of doubt, no Order will be placed under the Framework Agreement for that Test until the Test has received full Phase 3 Validation using the sampling method which is the subject of the LFT Proposal.

In fact, here's a link to all the tender documents, if anybody is short of bedtime reading tonight:

https://health-family-contract-search.secure.force.com/ProSpend__CS_ContractPage?SearchType=projects&uid=a074J000007FVWuQAO&searchStr=&sortStr=Recently+Published&page=1&filters=

Here's a link to the full tender test specification:

https://health-family-contract-search.secure.force.com/servlet/servlet.FileDownload?retURL=%2Fapex%2FProSpend__CS_ContractPage&file=00P4J00000DQNtPUAX

Spot on jdt1990. I agree that the exclusion of nasopharyngeal is down to the upcoming school testing programme.

So, the govt accidentally forgot to exclude oropharyngeal swabs from this tender Arnold?
Maybe you should give them a call and point out their error.

AP, have you got your own personalised copy of this new tender? Please do tell where it says only 'non-invasive' tests will be considered? I'm all for being positive about an investment, but you just can't keep making it up as you go along. Sticking to the facts is always a good policy in my experience.

Having been a little concerned about the absence of any mention of Abingdon in the company's last couple of RNS's, I've been having a read through Abingdon's Admission Document for the 15th Dec IPO. Was happy to see the following paragraph in there:

[7. Customers & Competitive Environment
Customers
Abingdon Health undertakes work for contract development and contract manufacturing clients spanning
the healthcare sector and other industries. Its clients in the UK include Avacta plc, Concepta plc and the
DHSC]

Quite re-assuring to see that the Abingdon/Avacta relationship is ongoing. I was also interested to know what their manufacturing capacity is. I found that it will be 1 million tests per week by the end of this year, but that will increase significantly in 2021:

[8. Strategy
The Group’s long-term strategic objective is to become the largest manufacturer of lateral flow tests globally,
providing development and contract manufacturing services to clients spanning a range of applications
across the healthcare and non-healthcare sectors.
The Board is, in the short-term, seeking to continue the expansion of Abingdon Health’s lateral flow test
automated manufacturing capacity such that, by the end of 2021, the Group intends to have capacity of
150 million tests per annum.]

So, it seems that the capacity will be there when we finally put the finishing touches to our gold standard test.

Before someone says it, I know CE Mark is a European standard certification ("Conformité Européenne“), but just wondering what markets that opens up for you. Also, there’s WHO approval and what markets that opens up for you. All gets a bit confusing.

I'd like to know what the difference is between CE Mark and MHRA approval. Is it that you need MHRA to be considered for UK govt contracts, whereas with CE Mark you can sell worldwide, but not to the UK govt?

Yes, looks like website in development. The phone number at the top of the home page is a give away - '123456789'. Just tried it, but no answer.

leewill: Omega will manufacture and sell the Mologic test under it's own Visitect branding. So, whilst Mologic will be selling the tests to poorer countries at a lower cost, Omega will sell them to govt's at a 'normal' price. Anyway, happy today to have made back £50k of the monies that the MM's robbed from me on 9th Nov. Avacta's turn next.

Didn't say they were 'still' experimenting, I said that they've been experimenting...implying past tense. Anyway, just a bit of speculation. What else is there to do!

I also wondered about that, especially in the light of the fact Matt Handjob said they would be manufacturing the Innova test here in the UK. Surely, he can't be still thinking of doing that after their credibility's been destroyed?

It might be why AS started using the term LFT 'programme' - you never know...

Mologic haven't confirmed anything. They've been experimenting with different kinds of reagents, aptamers being one of them.

Why not? If they get royalty payments from it, more to the good. Don't forget Mologic have also been working with Cytiva.

Very interesting Derbyone. The Mologic antigen test that's currently in TT to Omega is a bit of a mystery at the moment, in terms of sample type, reagent & SS. Who knows could be an Avacta->Mologic->Omega tie up. Will be fascinating to see how all these mysteries play out. It's getting a bit like the Whodunnit series.

Here’s a list of Covid tests the French will accept for Lorry drivers.
https://mobile.twitter.com/alexIholroyd/status/1341467694730801154/photo/1

Courtesy of PL:

https://bit.ly/3mOhIVP

Strange how they are giving nurses boxes of Innova tests to take home. Isn't that home use? Or, is this something different, given that nurses are 'professionals'?